$18.41
0.281.54%
At close: -
$18.41
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Viridian Therapeutics (NASDAQ:VRDN) Stock, Earnings Estimates, EPS, And Revenue
Viridian Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 25
EPS Estimate
$-1.000
Quarterly Revenue Estimate
$48.77K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$302.00K
Analyze the earnings history of Viridian Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Viridian Therapeutics (VRDN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-1.15 | $-1.05 | -9.52 % |
| Q2 | 2024-08-08 | $-1.02 | $-0.89 | -14.6 % |
| Q1 | 2024-05-08 | $-0.79 | $-1.10 | 28.2 % |
| Q4 | 2024-02-27 | $-1.35 | $-1.00 | -35.0 % |
Viridian Therapeutics (VRDN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $86.00K | $40.00K | 115.0 % |
| Q2 | 2024-08-08 | $72.00K | $90.00K | -20.0 % |
| Q1 | 2024-05-08 | $72.00K | $70.00K | 2.86 % |
| Q3 | 2023-11-13 | $72.00K | $110.00K | -34.5 % |
FAQ
When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?
Viridian Therapeutics (VRDN) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Viridian Therapeutics (NASDAQ:VRDN)?
The Actual EPS was $-1.15, which missed the estimate of $-1.05.
What were Viridian Therapeutics’s (NASDAQ:VRDN) revenues?
The Actual Revenue was $86K, which beat the estimate of $40K.
Browse earnings estimates, EPS, and revenue on all stocks.